Financial Ratios Health Logic Interactive Inc.
Stocks
CHIP.H
CA42227N3067
Investment Holding Companies
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0350 CAD | -.--% |
|
-.--% | - |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -315.24 | -119.36 | -43.49 | -142.1 | -134.53 | |||||
Return on Total Capital | 857.33 | 125.11 | 5.62 | 6.82 | 8.49 | |||||
Return On Equity % | -2.76K | 275.89 | 23.39 | -56.5 | 15.89 | |||||
Return on Common Equity | -2.76K | 275.89 | 23.39 | -56.5 | 15.89 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | - | - | - | - | - | |||||
SG&A Margin | - | - | - | - | - | |||||
EBITDA Margin % | - | - | - | - | - | |||||
EBITA Margin % | - | - | - | - | - | |||||
EBIT Margin % | - | - | - | - | - | |||||
Income From Continuing Operations Margin % | - | - | - | - | - | |||||
Net Income Margin % | - | - | - | - | - | |||||
Net Avail. For Common Margin % | - | - | - | - | - | |||||
Normalized Net Income Margin | - | - | - | - | - | |||||
Levered Free Cash Flow Margin | - | - | - | - | - | |||||
Unlevered Free Cash Flow Margin | - | - | - | - | - | |||||
Asset Turnover | ||||||||||
Asset Turnover | - | - | - | - | - | |||||
Fixed Assets Turnover | - | - | - | - | - | |||||
Receivables Turnover (Average Receivables) | - | - | - | - | - | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.15 | 0.01 | 0.01 | 0.05 | 0.03 | |||||
Quick Ratio | 0.14 | 0.01 | 0.01 | 0.05 | 0.03 | |||||
Operating Cash Flow to Current Liabilities | -2.2 | -0.01 | -0.05 | -0.29 | -0.06 | |||||
Days Sales Outstanding (Average Receivables) | - | - | - | - | - | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | -23.52 | -0.45 | -5.28 | -22.19 | -27.32 | |||||
Total Debt / Total Capital | -30.76 | -0.45 | -5.58 | -28.52 | -37.59 | |||||
LT Debt/Equity | - | - | - | - | - | |||||
Long-Term Debt / Total Capital | - | - | - | - | - | |||||
Total Liabilities / Total Assets | 102.31 | 523.62 | 2.76K | 1.7K | 3K | |||||
EBIT / Interest Expense | -165.35 | - | -11.41 | -4.76 | -2.04 | |||||
EBITDA / Interest Expense | - | - | - | - | - | |||||
(EBITDA - Capex) / Interest Expense | - | - | - | - | - | |||||
Total Debt / EBITDA | - | - | - | - | - | |||||
Net Debt / EBITDA | - | - | - | - | - | |||||
Total Debt / (EBITDA - Capex) | - | - | - | - | - | |||||
Net Debt / (EBITDA - Capex) | - | - | - | - | - | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | - | - | - | - | - | |||||
Gross Profit, 1 Yr. Growth % | - | - | - | - | - | |||||
EBITDA, 1 Yr. Growth % | - | - | - | - | - | |||||
EBITA, 1 Yr. Growth % | 461.35 | -60.86 | -90.23 | -16.68 | -46.41 | |||||
EBIT, 1 Yr. Growth % | 461.35 | -60.86 | -90.23 | -16.68 | -46.41 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -2.42K | -112.17 | -81.16 | -277.37 | -114.63 | |||||
Net Income, 1 Yr. Growth % | -1.81K | -115.15 | -81.16 | -277.37 | -114.63 | |||||
Normalized Net Income, 1 Yr. Growth % | 435.14 | -66.1 | -88.18 | -7.21 | -34.34 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -963.64 | -108.95 | -81.16 | -277.37 | -104.15 | |||||
Accounts Receivable, 1 Yr. Growth % | - | - | - | - | - | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | - | - | - | - | - | |||||
Total Assets, 1 Yr. Growth % | 307.94 | -71.3 | -79.88 | -47.73 | -35.09 | |||||
Tangible Book Value, 1 Yr. Growth % | -97.68 | 5.16K | 26.48 | -68.53 | 17.26 | |||||
Common Equity, 1 Yr. Growth % | -97.68 | 5.16K | 26.48 | -68.53 | 17.26 | |||||
Cash From Operations, 1 Yr. Growth % | 508.75 | -99.65 | 871.84 | 94.66 | -78.41 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 773.14 | -129.84 | -117.7 | 1.78K | -97.65 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 1.01K | -130.14 | -115.84 | 1.97K | -99.02 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | - | - | - | - | - | |||||
Gross Profit, 2 Yr. CAGR % | - | - | - | - | - | |||||
EBITDA, 2 Yr. CAGR % | - | - | - | - | - | |||||
EBITA, 2 Yr. CAGR % | 397.32 | 48.22 | -80.46 | -71.47 | -33.18 | |||||
EBIT, 2 Yr. CAGR % | 397.32 | 48.22 | -80.46 | -71.47 | -33.18 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 1.07K | 67.91 | -84.86 | -42.19 | -49.07 | |||||
Net Income, 2 Yr. CAGR % | 333.23 | 61.06 | -83.11 | -42.19 | -49.07 | |||||
Normalized Net Income, 2 Yr. CAGR % | 403.2 | 34.7 | -79.98 | -66.89 | -21.95 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 617.15 | -12.1 | -87.11 | -42.19 | -72.86 | |||||
Accounts Receivable, 2 Yr. CAGR % | - | - | - | - | - | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | - | - | - | - | - | |||||
Total Assets, 2 Yr. CAGR % | 223.83 | 8.2 | -75.97 | -67.57 | -41.75 | |||||
Tangible Book Value, 2 Yr. CAGR % | -75.88 | 10.58 | 715.84 | -36.91 | -39.26 | |||||
Common Equity, 2 Yr. CAGR % | -75.88 | 10.58 | 715.84 | -36.91 | -39.26 | |||||
Cash From Operations, 2 Yr. CAGR % | 628.3 | -85.33 | -81.46 | 334.95 | -35.17 | |||||
Capital Expenditures, 2 Yr. CAGR % | - | - | - | - | - | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 46.05 | 61.42 | -77.02 | 82.32 | -33.59 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 45.32 | 82.64 | -78.13 | 81.16 | -54.93 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | - | - | - | - | - | |||||
Gross Profit, 3 Yr. CAGR % | - | - | - | - | - | |||||
EBITDA, 3 Yr. CAGR % | - | - | - | - | - | |||||
EBITA, 3 Yr. CAGR % | 29.58 | 113.12 | -40.15 | -68.31 | -64.8 | |||||
EBIT, 3 Yr. CAGR % | 29.58 | 113.12 | -40.15 | -68.31 | -64.8 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 127.91 | 154.82 | -19.01 | -65.61 | -63.44 | |||||
Net Income, 3 Yr. CAGR % | 34.93 | 41.67 | -21.23 | -63.01 | -63.44 | |||||
Normalized Net Income, 3 Yr. CAGR % | 31.17 | 104.76 | -40.15 | -66.63 | -58.4 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 57.73 | 66.33 | -47.64 | -69.11 | -75.97 | |||||
Accounts Receivable, 3 Yr. CAGR % | - | - | - | - | - | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | - | - | - | - | - | |||||
Total Assets, 3 Yr. CAGR % | 124.09 | 44.38 | -38.25 | -68.87 | -59.13 | |||||
Tangible Book Value, 3 Yr. CAGR % | -72.53 | 45.22 | 15.64 | 175.65 | -22.43 | |||||
Common Equity, 3 Yr. CAGR % | -72.53 | 45.22 | 15.64 | 175.65 | -22.43 | |||||
Cash From Operations, 3 Yr. CAGR % | 4.67 | -42.75 | -40.63 | -59.4 | 59.84 | |||||
Capital Expenditures, 3 Yr. CAGR % | - | - | - | - | - | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 29.95 | -13.98 | -22.74 | -0.27 | -57.26 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 29.28 | -13.98 | -19.11 | -0.31 | -68.19 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
EBITDA, 5 Yr. CAGR % | - | - | - | - | - | |||||
EBITA, 5 Yr. CAGR % | 5.65 | -19.68 | -39.2 | -4.68 | -37.45 | |||||
EBIT, 5 Yr. CAGR % | 4.42 | -20.29 | -39.2 | -4.68 | -37.45 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 27.5 | -27 | -22.96 | 40.78 | -32.73 | |||||
Net Income, 5 Yr. CAGR % | 22.04 | -27 | -41.23 | -1.02 | -33.84 | |||||
Normalized Net Income, 5 Yr. CAGR % | 5.03 | -22.1 | -38.16 | -1.2 | -33.44 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -20.37 | -47.73 | -42.07 | 8.68 | -59.74 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | - | - | - | |||||
Total Assets, 5 Yr. CAGR % | 8.65 | -25.52 | -8.26 | -20.56 | -39.67 | |||||
Tangible Book Value, 5 Yr. CAGR % | -36.85 | 50.43 | 6.64 | 4.04 | -10.61 | |||||
Common Equity, 5 Yr. CAGR % | -42.18 | 14.9 | 6.64 | 4.04 | -10.61 | |||||
Cash From Operations, 5 Yr. CAGR % | 16.96 | -69.12 | -47.62 | 28.83 | -38.51 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 23.77 | -26 | -35.01 | 16.17 | -27.28 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 23.65 | -25.98 | -36.49 | 15.91 | -35.98 |
- Stock Market
- Stocks
- CHIP.H Stock
- Financials Health Logic Interactive Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















